SCHEMBL16015488

SCHEMBL16015488

CN1CCC(NCC(O)CO)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 3/20 0.49
ADRB3 P13945 3/20 0.49
ADRB2 P07550 2/20 0.49
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
KDM4E B2RXH2 1/20 0.47
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
DPP7 Q9UHL4 1/20 0.41
PTPN11 Q06124 2/20 0.38
HRH1 P35367 1/20 0.36
HRH4 Q9H3N8 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
MITF O75030 1/20 0.35
SLC2A1 P11166 1/20 0.34
SLC6A2 P23975 1/20 0.34
DRD2 P14416 1/20 0.33
DRD4 P21917 1/20 0.33
DRD3 P35462 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22280550 0.82 SMN1; SMN2 (0.47) ADRB1ADRB3ADRB2CYP3A4CYP2D6
SCHEMBL22520374 0.82 SMN1; SMN2 (0.47) ADRB1ADRB3ADRB2CYP3A4CYP2D6
SCHEMBL20980205 0.82 KDM4E (0.44) ADRB1ADRB3ADRB2CYP3A4CYP2D6
SCHEMBL10857129 0.82
SCHEMBL18756405 0.81 KDM4E (0.41) ADRB1ADRB3ADRB2CYP3A4CYP2D6
SCHEMBL16015490 0.81 ADRB2 (0.48) ADRB1ADRB3ADRB2CYP3A4CYP2D6
SCHEMBL22545051 0.81 ADRB1 (0.55) ADRB1ADRB3ADRB2CYP3A4CYP2D6
SCHEMBL12228088 0.78 ADRB2 (0.44) ADRB1ADRB3ADRB2CYP3A4CYP2D6
SCHEMBL6644034 0.78 KDM4E (0.75) ADRB2KDM4EHTTSMN1; SMN2MEN1
SCHEMBL16822348 0.76 KDM4E (0.79) ADRB1ADRB2KDM4EHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3381920-B1 CDK INHIBITORS G1 THERAPEUTICS INC (US) 2019-03-27 EP disclosed
US-8829012-B2 CDK inhibitors G1 THERAPEUTICS, INC. (US) 2014-09-09 US disclosed